2009
DOI: 10.1016/j.bmc.2009.03.009
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and biological evaluation of novel conjugates of podophyllotoxin and 5-FU as antineoplastic agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
16
0

Year Published

2010
2010
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 31 publications
(16 citation statements)
references
References 33 publications
0
16
0
Order By: Relevance
“…The cytotoxicity data (IC 50 ; μM) of the two different series of podophyllotoxin analogues such as 4 -[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxins (10) and conjugates of podophyllotoxin and 5-FU (11) against four different cancer cell lines was considered for the QSAR analysis [17,18]. The cytotoxicity data (IC 50 ; μM) of compound series (10 and 11) was converted into log 1/IC 50 (molar concentration) and listed in Tables 1 and 2.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The cytotoxicity data (IC 50 ; μM) of the two different series of podophyllotoxin analogues such as 4 -[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxins (10) and conjugates of podophyllotoxin and 5-FU (11) against four different cancer cell lines was considered for the QSAR analysis [17,18]. The cytotoxicity data (IC 50 ; μM) of compound series (10 and 11) was converted into log 1/IC 50 (molar concentration) and listed in Tables 1 and 2.…”
Section: Methodsmentioning
confidence: 99%
“…In a very recent work, Chen et al [18] reported the synthesis of a series of conjugates of podophyllotoxin together with 5-FU (11), in which the main chemical differences are the length of the side chain (where, Y = CH 2 , CH 2 CH 2 , or CH 2 CH 2 CH 2 ), and the difference of amino acids. They also evaluated their cytotoxicity in in-vitro against four different human cancer cell lines.…”
Section: Qsars For the In-vitro Cytotoxicities Of The Conjugates Of Pmentioning
confidence: 99%
“…For example, thiocolchicine-podophyllotoxin conjugates were reported to have improved solubility and anticancer activity [15]. In addition, a series of conjugates of podophyllotoxin with 5-fluorouracil (5-FU) were reported to have better cytotoxic activity than VP-16 [16]. Structure-activity relationship (SAR) studies [17] have demonstrated that C-4 is the molecular area tolerable to significant structural diversification.…”
Section: Introductionmentioning
confidence: 99%
“…15,16 In light of the combined use of camptothecin (CPT) and 5-FU in clinical therapy, the conjugation of 5-FU and CPT with dipeptides improved tumor selectivity, efficiency, safety, and were comparable or superior to irinotecan. 17 Other hybrids, incorporating various pharmacophores with antitumor activity including cytarabine-5-FU, 18 cisplatin-5-FU, 19 podophyllotoxin-5-FU, 20 ampelopsin-5-FU, 21 inhanced 5-FU's physical and chemical profiles and overcame its disadvantages. With these exciting results achieved so far, 5-FU was an attractive lead compound for the development of novel antitumor agents, but few modifications were found at O 2 or O 4 positions.…”
Section: 4mentioning
confidence: 99%